Explore more publications!
Mongolia Healthcare Journal
Got News to Share?

Mongolia Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mongolia Healthcare Journal.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 19, 2026

Magnesium Niacinamide Relief Topical Cream: What Consumers Are Researching Before Buying in 2026
Feb. 19, 2026

Magnesium Niacinamide Relief Topical Cream: What Consumers Are Researching Before Buying in 2026

Indeterminate GlobeNewswire
The Will of the People Prevails: Citizen-Led, Cross-Partisan Effort Delivers Major Win for Wisconsin Moms
Feb. 19, 2026

The Will of the People Prevails: Citizen-Led, Cross-Partisan Effort Delivers Major Win for Wisconsin Moms

Indeterminate GlobeNewswire
Sienna Reports Fourth Quarter 2025 Financial Results and Continues Platform Growth
Feb. 19, 2026

Sienna Reports Fourth Quarter 2025 Financial Results and Continues Platform Growth

Indeterminate GlobeNewswire
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026
Feb. 19, 2026

Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026

Indeterminate GlobeNewswire
Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
Feb. 19, 2026

Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis

Indeterminate GlobeNewswire
Curaechoice and The Center for Pain to Deliver No-Cost Pain Management to Members Nationwide
Feb. 19, 2026

Curaechoice and The Center for Pain to Deliver No-Cost Pain Management to Members Nationwide

Indeterminate GlobeNewswire
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Feb. 19, 2026

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen

Indeterminate GlobeNewswire
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Feb. 19, 2026

Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb. 19, 2026

BioAge Labs to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

Indeterminate GlobeNewswire
AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
Feb. 19, 2026

AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results

Indeterminate GlobeNewswire
STRATA Skin Sciences Confirms Nasdaq Delisting
Feb. 19, 2026

STRATA Skin Sciences Confirms Nasdaq Delisting

Indeterminate GlobeNewswire
Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference
Feb. 19, 2026

Beta Bionics to Present at the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
Feb. 19, 2026

ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

Indeterminate GlobeNewswire
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
Feb. 19, 2026

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026

Indeterminate GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Feb. 19, 2026

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire
Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina
Feb. 19, 2026

Nanox Expands in Latin America with Exclusive Nanox.ARC Distribution Agreement in Argentina

Indeterminate GlobeNewswire
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Feb. 19, 2026

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Indeterminate GlobeNewswire
Candel Therapeutics Announces Proposed $100 Million Public Offering
Feb. 19, 2026

Candel Therapeutics Announces Proposed $100 Million Public Offering

Indeterminate GlobeNewswire
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb. 19, 2026

Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  
Feb. 19, 2026

Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur  

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions